HINDBIO
Hindustan Bio Sciences financials
- Market cap
- ₹9 Cr
Quarterly results
Q1 FY27: revenue down 100.0%, net profit down 1200.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 −100% | 0 | 0 −100% | 0 −100% |
| EBITDA | 0 | -0 | 0 | 0 | -0 −186% | 0 +275% | -0 −210% | -0 |
| Net profit | 0 | -0 | 0 | 0 | -0 −175% | 0 +300% | -0 −209% | -0 −1200% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +1.4% 1Y
1Y: ₹7.81 on 9 Sept 2025 → ₹7.92. High ₹9.66 (22 Apr 2026), low ₹5.03 (30 Dec 2025).
Financials, as filed
Revenue fell 17.6% a year over 2 years, FY24 to FY26. Operating margin narrowed to -14.3%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Operating profit | ₹0 Cr | ₹0 Cr | ₹-0 Cr |
| Operating margin | 3.9% | 16.7% | -14.3% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | ₹-0 Cr |
| Net margin | 5.8% | 19.2% | -12.9% |
| Cash from operations | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| Free cash flow | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| ROCE | 1.5% | 3.0% | -2.4% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹10 Cr | ₹10 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Reserves | ₹-9 Cr | ₹-9 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| Borrowings | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| Other liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Total liabilities | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Total assets | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025.
- Promoters
- 12.2%
- Public
- 87.8%
Since Jun 2025
- Promoters 0.00 pp
- Public 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 12.2%, Public 87.8%.Dec '23: Promoters 12.2%, Public 87.8%.Mar '24: Promoters 12.2%, Public 87.8%.Jun '24: Promoters 12.2%, Public 87.8%.Sep '24: Promoters 12.2%, Public 87.8%.Dec '24: Promoters 12.2%, Public 87.8%.Mar '25: Promoters 12.2%, Public 87.8%.Jun '25: Promoters 12.2%, Public 87.8%.Sep '25: Promoters 12.2%, Public 87.8%.Dec '25: Promoters 12.2%, Public 87.8%.Mar '26: Promoters 12.2%, Public 87.8%.Jun '26: Promoters 12.2%, Public 87.8%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Danlaw Systems India Ltd newly disclosed 1.30% held
- Bosco Armando Menezes +0.08 pp 2.71% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Hindustan Bio Sciences Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Venkata Rama Mohan Raju Jampana | 9.39% | unchanged |
| Super Solutions India Private Limited | 2.78% | unchanged |
| Bosco Armando Menezes | 2.71% | +0.08 pp |
| Satyasai Kolli | 2.59% | unchanged |
| Emily Bosco Menezes | 2.49% | unchanged |
| Madhusudan Rao Polineni | 1.61% | unchanged |
| Chintalapati Deepika | 1.37% | unchanged |
| Danlaw Systems India Ltd | 1.30% | newly disclosed |
| Smitha Polineni | 1.08% | unchanged |
| J Varun Varma | 0.02% | unchanged |
| J Uma | 0.01% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Hindustan Bio Sciences Ltd.
Guides on how to read this kind of business and the numbers that matter.